Benchtop DNA printers are coming soon—and biosecurity experts are worried
By Robert F. Service,
Science
| 05. 11. 2023
Biologists who have been obtaining DNA sequences online from companies will soon have a more convenient option: benchtop machines that can print all the DNA they need. But this technology brings with it new risks by circumventing how synthetic biology companies now screen for would-be bioterrorists. A report released yesterday by a Washington, D.C., think tank urges companies and governments to revamp existing screening to prevent someone with malign motives from making a toxin or pathogen.
The current screening system, which is voluntary, “could be upended by benchtop DNA synthesis,” says report co-author Jaime Yassif, vice president for global biological policy and programs at the Nuclear Threat Initiative. “Governments, industry, and the broader scientific community need to put stronger safeguards in place to ensure this technology is not exploited by malicious actors and that it doesn’t lead to a catastrophic accident,” she says.
The ability to synthesize DNA has been around since the early 1980s. The technology has become a central component of genetic research and is used to develop novel pharmaceuticals, agricultural products, and biofuels. Synthetic DNA sequences are...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...